Qingqing Yi
Director · BeOne Medicines Ltd.
- 2026
- Jun 3, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Qingqing Yi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John Oyler - $189.61M in ONC purchases and sales in the last 12 months
- Xiaodong Wang - $24.68M in ONC purchases and sales in the last 12 months
- Xiaobin Wu - $8.75M in ONC purchases and sales in the last 12 months
- Chan Henry Lee - $4.20M in ONC purchases and sales in the last 12 months
- Lai Wang - $1.17M in ONC purchases and sales in the last 12 months
- Corazon (Corsee) D. Sanders - $961K in ONC purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Qingqing Yi?
Qingqing Yi is a corporate insider, tracked as Director of BeOne Medicines Ltd. (ONC). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Qingqing Yi last file a Form 4?
The only primary Form 4 on record is dated 3 June 2026.
Has Qingqing Yi been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($66K) across all tracked filings.